Annemieke Aartsma-Rus featured in a press release on the LUMC website last week.
In this she speaks about the role of Academic Pharma in supporting the process of delivering drugs that are not interesting for pharmaceutical companies, because of the low numbers of patients. Also, the role of DCRT in this process is raised.